[DailyStraits]Homegrown DOC2US Launches Rapid Test Kits
Homegrown DOC2US Launches Rapid Test Kits
Kuala Lumpur, July 26: DOC2US has launched its proprietary system to test, record, manage and report COVID-19 cases for corporations and the public.
The system provides a cost-effective, credible and convenient means to comply with guidelines set by the Ministry of International Trade and Industry for economic sectors allowed to operate under phase two of the National Recovery Plan.
‘The MITI guidelines require employees to be screened for COVID-19 twice before a resumption of work and twice per week thereafter,’ DOCS2US CEO Dr Raymond Choy said in a media statement.
‘With most businesses suffering a loss of revenue due to the lockdowns, it is critical to provide a credible solution that is convenient and economical, thus enabling sectors to resume their activities while complying with the MITI guidelines.’
RTKis (pronounces as Ar-Tee-kis) is a comprehensive solution consists of a Medical Device Authority (MDA) approved home-use RTK antigen test kit that allows user to conduct COVID-19 self-testing at home with their identity verification and test process validation as well as test result validation using artificial intelligent (AI) on the DOC2US RTKis platform.
Positive results will then be uploaded to the Public Health Laboratory Information System (SIMKA) which is synchronised with the MySejehtera app.
Introducing DOC2US, your personal pocket doctor at your fingertips. With its name synonymous to “talk to us”, DOC2US is a mobile application that allows you to talk to a doctor or any healthcare professionals via text chat at any time and from anywhere.